Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DB25FSYYG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,623
Award facts
- Contract value 100% obligated
- $8,622.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $8,622.72, awards DMS Pharmaceutical Group Inc. a firm fixed-price contract for the supply of Xtandi 40 mg capsules (120 count) to the Defense Logistics Agency (DLA). The award, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery at its primary location in Park Ridge, IL 60068. This delivery order is issued under the company's existing single-award Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide.
Xtandi is an oral prescription medication used primarily in oncology treatment. The DLA's utilization of this delivery order mechanism reflects its systematic approach to maintaining critical pharmaceutical inventories for military health system operations. DMS Pharmaceutical Group has established itself as a significant federal pharmaceutical supplier through consistent contract performance across diverse product categories, including specialty medications, biologics, and branded prescription drugs. The company's status as a woman-owned small business, combined with its established SAM.gov registration since 2001, positions it as a competitive and reliable source for pharmaceutical distribution to federal healthcare agencies.
Quick answers
Who was awarded contract SPE2DB25FSYYG?
SPE2DB25FSYYG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FSYYG worth?
The government has obligated $8,623 on SPE2DB25FSYYG.
Is contract SPE2DB25FSYYG an order under another contract?
Yes. SPE2DB25FSYYG is a delivery order under SPE2DB25D9349, an indefinite delivery contract.
Was contract SPE2DB25FSYYG competed?
The extent of competition for SPE2DB25FSYYG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award